News

List prices frozen until 2023

Despite the ongoing challenges faced by the whole industry, we are demonstrating our commitment to supporting stem cell researchers by freezing our prices until January 1st, 2023. Furthermore, we will include free shipping on all orders moving forward.
Qkine celebrates ISO9001:2015 certification
News

Qkine earns ISO 9001:2015 certification for protein R&D and manufacture facilities in Cambridge, UK

Qkine certified ISO9001: 2015 for its quality management system encompassing R&D, manufacturing, and operations in Cambridge, UK. Qkine supplies growth factors and cytokines to the fast-moving stem cell, organoid and emerging cultured meat sectors. Exceptional product quality and scientific support are crucial to customer's business processes and experimental outcomes.
FGF 2-G3 (FGF2-STAB) for weekend-free stem cell culture
News

Qkine and Enantis sign licensing deal for hyperstable FGF2-STAB®

Qkine and Enantis have concluded a global licensing deal for Enantis’s patented FGF2-STAB® technology. FGF2-STAB® is a hyperstable form of FGF-2 (bFGF), a core reagent for stem cell culture. FGF2-STAB (FGF2-G3) does not degrade in culture media for enhanced weekend-free stem cell culture media and advanced chemically defined systems, such as those needed in the cultured meat industry.
News

Rob Nixon joins Qkine as Head of Commercial and Dr Cassie Doherty is appointed to the board

Cambridge, UK 21 July 2020: Qkine â€“ a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications […]
News

Qkine secures £1.5M series A funding from leading life science investors

Cambridge, UK 08 June 2020: Qkine â€“ a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications […]
News

Qkine secures additional £550K to extend development of R&D pipeline and accelerate commercialisation of product portfolio

Cambridge, UK 03 June 2019: Qkine, specialist manufacturer of proteins for stem cell, organoid and regenerative medicine applications, has closed a […]
News

Qkine backed by Cambridge Enterprise and a quintet of angels

University of Cambridge spin-out Qkine has closed its seed investment round supported by Cambridge Enterprise, the commercialisation arm of the University, and a […]
Shopping Basket